| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |